Fig. 1From: Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfaCLN2 clinical rating scale (CLN2 CRS) in patient 1 (bullets) and patient 2 (boxes) during two years of treatment with cerliponase alfa. Closed bullets/boxes represent total sum score of all four domains and open bullets/boxes represent the sum score of the motor and language domainBack to article page